These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF SECURITIES EXCHANGE ACT OF 1934
|
A
|
(
|
IRS employer identification number
|
Title of Each Class
|
Trading Symbol(s)
|
Name of Each Exchange on Which Registered
|
|
|
|
Large accelerated filer
☒
|
Accelerated filer
☐
|
Non-accelerated filer
☐
|
Small reporting company
|
Emerging growth company
|
● |
risks associated with our substantial indebtedness and debt service;
|
● |
changes in prices and availability of resin and other raw materials and our ability to pass on changes in raw material prices to our customers on a timely basis;
|
● |
risks related to acquisitions or divestitures and integration of acquired businesses and their operations, and realization of anticipated cost savings and synergies;
|
● |
uncertainty regarding the United Kingdom’s withdrawal from the European Union and the outcome of future arrangements between the United Kingdom and the European Union;
|
● |
reliance on unpatented proprietary know-how and trade secrets;
|
● |
the phase-out of the London Interbank Offered Rate (LIBOR), or the replacement of LIBOR with a different reference rate or modification of the method used to calculate LIBOR, which may adversely affect interest rates;
|
● |
increases in the cost of compliance with laws and regulations, including environmental, safety, anti-plastic legislation, production and product laws and regulations;
|
● |
employee shutdowns or strikes or the failure to renew effective bargaining agreements;
|
● |
risks related to disruptions in the overall economy and the financial markets that may adversely impact our business;
|
● |
risks of catastrophic loss of one of our key manufacturing facilities, natural disasters, and other unplanned business interruptions;
|
● |
risks related to the failure of, inadequacy of or attacks on our information technology systems and infrastructure;
|
● |
risks related to market acceptance of our developing technologies and products;
|
● |
general business and economic conditions, particularly an economic downturn;
|
● |
ability of our insurance to fully cover potential exposures;
|
● |
risks that our restructuring programs may entail greater implementation costs or result in lower savings than anticipated;
|
● |
risks related to future write-offs of substantial goodwill;
|
● |
risks of competition, including foreign competition, in our existing and future markets;
|
● |
new legislation or new regulations and the Company's corresponding interpretations of either may affect our business and consolidated financial condition and results of operations; and
|
● |
the other factors discussed in the section titled “Risk Factors.”
|
|
Page
|
|
PART I
|
||
3
|
||
6
|
||
10
|
||
10
|
||
10
|
||
10
|
||
PART II
|
||
11
|
||
12
|
||
12
|
||
22
|
||
23
|
||
24
|
||
24
|
||
24
|
||
PART III
|
||
25
|
||
25
|
||
25
|
||
25
|
||
25
|
||
PART IV
|
||
26
|
||
26
|
||
● |
make it more difficult for us to satisfy our obligations under our indebtedness;
|
● |
limit our ability to borrow money for our working capital, capital expenditures, product development, debt service requirements or other corporate purposes;
|
● |
require us to dedicate a substantial portion of our cash flow to payments on our indebtedness, which would reduce the amount of cash flow available to fund working capital, capital expenditures, product development and other corporate requirements;
|
● |
increase our vulnerability to general adverse economic and industry conditions; and
|
● |
limit our ability to respond to business opportunities, including growing our business through acquisitions.
|
Geographic Region
|
Total Facilities
|
Leased Facilities
|
||
North America
|
123
|
31
|
||
Europe, Middle East, India, Africa
|
149
|
44
|
||
South America
|
7
|
2
|
||
Asia Pacific
|
24
|
13
|
|
Fiscal 2019
|
Fiscal 2018
|
Fiscal 2017
|
Fiscal 2016
|
Fiscal 2015
|
|||||||||||||||
Statement of Operations Data:
|
||||||||||||||||||||
Net sales
|
$
|
8,878
|
$
|
7,869
|
$
|
7,095
|
$
|
6,489
|
$
|
4,881
|
||||||||||
Operating income
|
974
|
761
|
732
|
581
|
408
|
|||||||||||||||
Net income
|
404
|
496
|
340
|
236
|
86
|
|||||||||||||||
Net Income Per Share Data:
|
||||||||||||||||||||
Basic, net income per share
|
$
|
3.08
|
$
|
3.77
|
$
|
2.66
|
$
|
1.95
|
$
|
0.72
|
||||||||||
Diluted, net income per share
|
3.00
|
3.67
|
2.56
|
1.89
|
0.70
|
|||||||||||||||
Balance Sheet Data:
|
||||||||||||||||||||
Total assets
|
$
|
16,469
|
$
|
9,131
|
$
|
8,476
|
$
|
7,653
|
$
|
5,028
|
||||||||||
Long-term debt obligations
|
11,365
|
5,844
|
5,641
|
5,755
|
3,685
|
|||||||||||||||
Statement of Cash Flow Data:
|
||||||||||||||||||||
Net cash from operating activities
|
$
|
1,201
|
$
|
1,004
|
$
|
975
|
$
|
857
|
$
|
637
|
||||||||||
Net cash from investing activities
|
(6,251
|
)
|
(1,035
|
)
|
(774
|
)
|
(2,579
|
)
|
(165
|
)
|
||||||||||
Net cash from financing activities
|
5,426
|
113
|
(226
|
)
|
1,817
|
(365
|
)
|
Polyethylene Butene Film
|
Polypropylene
|
|||||||||||||||||||||||
2019
|
2018
|
2017
|
2019
|
2018
|
2017
|
|||||||||||||||||||
1st quarter
|
$
|
.64
|
$
|
.68
|
$
|
.56
|
$
|
.76
|
$
|
.71
|
$
|
.56
|
||||||||||||
2nd quarter
|
.61
|
.69
|
.58
|
.63
|
.75
|
.67
|
||||||||||||||||||
3rd quarter
|
.63
|
.68
|
.60
|
.62
|
.76
|
.61
|
||||||||||||||||||
4th quarter
|
.59
|
.66
|
.62
|
.62
|
.85
|
.62
|
Consolidated Overview
|
Fiscal Year
|
|||||||||||||||
2019
|
2018
|
$ Change
|
% Change
|
|||||||||||||
Net sales
|
$
|
8,878
|
$
|
7,869
|
$
|
1,009
|
13
|
%
|
||||||||
Operating income
|
$
|
974
|
$
|
761
|
$
|
213
|
28
|
%
|
||||||||
Operating income percentage of net sales
|
11
|
%
|
10
|
%
|
Consumer Packaging International
|
Fiscal Year
|
|||||||||||||||
2019
|
2018
|
$ Change
|
% Change
|
|||||||||||||
Net sales
|
$
|
1,229
|
$
|
215
|
$
|
1,014
|
472
|
%
|
||||||||
Operating income
|
$
|
12
|
$
|
17
|
$
|
(5
|
)
|
(29
|
)%
|
|||||||
Operating income percentage of net sales
|
1
|
%
|
8
|
%
|
Consumer Packaging North America
|
Fiscal Year
|
|||||||||||||||
2019
|
2018
|
$ Change
|
% Change
|
|||||||||||||
Net sales
|
$
|
2,636
|
$
|
2,463
|
$
|
173
|
7
|
%
|
||||||||
Operating income
|
$
|
234
|
$
|
190
|
$
|
44
|
23
|
%
|
||||||||
Operating income percentage of net sales
|
9
|
%
|
8
|
%
|
Engineered Materials
|
Fiscal Year
|
|||||||||||||||
2019
|
2018
|
$ Change
|
% Change
|
|||||||||||||
Net sales
|
$
|
2,538
|
$
|
2,633
|
$
|
(95
|
)
|
(4
|
)%
|
|||||||
Operating income
|
$
|
318
|
$
|
365
|
$
|
(47
|
)
|
(13
|
)%
|
|||||||
Operating income percentage of net sales
|
13
|
%
|
14
|
%
|
Health, Hygiene & Specialties
|
Fiscal Year
|
|||||||||||||||
2019
|
2018
|
$ Change
|
% Change
|
|||||||||||||
Net sales
|
$
|
2,475
|
$
|
2,558
|
$
|
(83
|
)
|
(3
|
)%
|
|||||||
Operating income
|
$
|
410
|
$
|
189
|
$
|
221
|
117
|
%
|
||||||||
Operating income percentage of net sales
|
17
|
%
|
7
|
%
|
Other expense, net
|
Fiscal Year
|
|||||||||||||||
2019
|
2018
|
$ Change
|
% Change
|
|||||||||||||
Other expense, net
|
$
|
155
|
$
|
25
|
$
|
130
|
520
|
%
|
Interest expense, net
|
Fiscal Year
|
|||||||||||||||
2019
|
2018
|
$ Change
|
% Change
|
|||||||||||||
Interest expense, net
|
$
|
329
|
$
|
259
|
$
|
70
|
27
|
%
|
Income tax (benefit) expense
|
Fiscal Year
|
|||||||||||||||
2019
|
2018
|
$ Change
|
% Change
|
|||||||||||||
Income tax (benefit) expense
|
$
|
86
|
$
|
(19
|
)
|
$
|
105
|
(553
|
)%
|
Comprehensive Income
|
Fiscal Year
|
|||||||||||||||
2019
|
2018
|
$ Change
|
% Change
|
|||||||||||||
Comprehensive Income
|
$
|
174
|
$
|
408
|
$
|
(234
|
)
|
(57
|
)%
|
Consolidated Overview
|
Fiscal Year
|
|||||||||||||||
2018
|
2017
|
$ Change
|
% Change
|
|||||||||||||
Net sales
|
$
|
7,869
|
$
|
7,095
|
$
|
774
|
11
|
%
|
||||||||
Operating income
|
$
|
761
|
$
|
732
|
$
|
29
|
4
|
%
|
||||||||
Operating income percentage of net sales
|
10
|
%
|
10
|
%
|
Consumer Packaging International
|
Fiscal Year
|
|||||||||||||||
2018
|
2017
|
$ Change
|
% Change
|
|||||||||||||
Net sales
|
$
|
215
|
$
|
200
|
$
|
15
|
8
|
%
|
||||||||
Operating income
|
$
|
17
|
$
|
23
|
$
|
(6
|
)
|
(26
|
)%
|
|||||||
Operating income percentage of net sales
|
8
|
%
|
12
|
%
|
Consumer Packaging North America
|
Fiscal Year
|
|||||||||||||||
2018
|
2017
|
$ Change
|
% Change
|
|||||||||||||
Net sales
|
$
|
2,463
|
$
|
2,351
|
$
|
112
|
5
|
%
|
||||||||
Operating income
|
$
|
190
|
$
|
200
|
$
|
(10
|
)
|
(5
|
)%
|
|||||||
Operating income percentage of net sales
|
8
|
%
|
9
|
%
|
Engineered Materials
|
Fiscal Year
|
|||||||||||||||
2018
|
2017
|
$ Change
|
% Change
|
|||||||||||||
Net sales
|
$
|
2,633
|
$
|
2,337
|
$
|
296
|
13
|
%
|
||||||||
Operating income
|
$
|
365
|
$
|
311
|
$
|
54
|
17
|
%
|
||||||||
Operating income percentage of net sales
|
14
|
%
|
13
|
%
|
Health, Hygiene & Specialties
|
Fiscal Year
|
|||||||||||||||
2018
|
2017
|
$ Change
|
% Change
|
|||||||||||||
Net sales
|
$
|
2,558
|
$
|
2,207
|
$
|
351
|
16
|
%
|
||||||||
Operating income
|
$
|
189
|
$
|
198
|
$
|
(9
|
)
|
(5
|
)%
|
|||||||
Operating income percentage of net sales
|
7
|
%
|
9
|
%
|
Other expense, net
|
Fiscal Year
|
|||||||||||||||
2018
|
2017
|
$ Change
|
% Change
|
|||||||||||||
Other expense, net
|
$
|
25
|
$
|
14
|
$
|
11
|
79
|
%
|
Interest expense, net
|
Fiscal Year
|
|||||||||||||||
2018
|
2017
|
$ Change
|
% Change
|
|||||||||||||
Interest expense, net
|
$
|
259
|
$
|
269
|
$
|
(10
|
)
|
(4
|
)%
|
Income tax (benefit) expense
|
Fiscal Year
|
|||||||||||||||
2018
|
2017
|
$ Change
|
% Change
|
|||||||||||||
Income tax (benefit) expense
|
$
|
(19
|
)
|
$
|
109
|
$
|
(128
|
)
|
(117
|
)%
|
Comprehensive Income
|
Fiscal Year
|
|||||||||||||||
2018
|
2017
|
$ Change
|
% Change
|
|||||||||||||
Comprehensive Income
|
$
|
408
|
$
|
420
|
$
|
(12
|
)
|
(3
|
)%
|
Payments due by period as of the end of fiscal 2019
|
||||||||||||||||||||
Total
|
< 1 year
|
1-3 years
|
4-5 years
|
> 5 years
|
||||||||||||||||
Long-term debt, excluding capital leases
|
$
|
11,356
|
$
|
67
|
$
|
134
|
$
|
3,736
|
$
|
7,419
|
||||||||||
Capital leases
(a)
|
123
|
36
|
54
|
22
|
11
|
|||||||||||||||
Fixed interest rate payments
|
1,120
|
200
|
399
|
307
|
214
|
|||||||||||||||
Variable interest rate payments
(b)
|
1,969
|
370
|
723
|
566
|
310
|
|||||||||||||||
Operating leases
|
554
|
108
|
174
|
103
|
169
|
|||||||||||||||
Total contractual cash obligations
|
$
|
15,122
|
$
|
781
|
$
|
1,484
|
$
|
4,734
|
$
|
8,123
|
(a) |
Includes anticipated interest of $9 million over the life of the capital leases.
|
(b) |
Based on applicable interest rates in effect end of fiscal 2019.
|
Years Ended
|
||||||||||||
September 28,
2019
|
September 29,
2018
|
September 30,
2017
|
||||||||||
Cash flow from operating activities
|
$
|
1,201
|
$
|
1,004
|
$
|
975
|
||||||
Additions to property, plant and equipment, net
|
(399
|
)
|
(333
|
)
|
(263
|
)
|
||||||
Payments of tax receivable agreement
|
(38
|
)
|
(37
|
)
|
(111
|
)
|
||||||
Free cash flow
|
$
|
764
|
$
|
634
|
$
|
601
|
|
Page
|
Reports of Independent Registered Public Accounting Firm
|
27
|
Consolidated Statements of Income and Comprehensive Income for fiscal 2019, 2018 and 2017
|
29
|
Consolidated Balance Sheets as of fiscal 2019 and 2018
|
30
|
Consolidated Statements of Changes in Stockholders' Equity for fiscal 2019, 2018 and 2017
|
31
|
Consolidated Statements of Cash Flows for fiscal 2019, 2018 and 2017
|
32
|
Notes to Consolidated Financial Statements
|
33
|
1. |
Financial Statements
|
2. |
Financial Statement Schedules
|
3. |
Exhibits
|
Valuation of Goodwill
|
||
Description of the Matter
|
At September 28, 2019, the Company had a goodwill balance of $5.1 billion. As discussed in Note 1 to the consolidated financial statements, goodwill is tested for impairment at least annually at the reporting unit level. The Company’s goodwill is initially assigned to its reporting units as of the acquisition date. In fiscal year 2019, the Company applied the qualitative impairment assessment and concluded that it was more likely than not that the fair value of each reporting unit exceeded the carrying amount except for their Health, Hygiene & Specialties – South America (HHS-SA) reporting unit, in which a quantitative test was performed due to the lower prior year amount of excess of fair value over carrying value for that reporting unit.
Auditing management’s annual goodwill impairment test for the HHS-SA reporting unit, in which the one-step impairment test was performed, was complex and judgmental due to the significant estimation required in determining the fair value of the reporting unit. The significant estimation uncertainty was primarily due to the sensitivity of the respective fair value to underlying assumptions about the future operating performance of the HHS-SA reporting unit. In particular, the fair value estimate was sensitive to significant assumptions in the prospective financial information such as the revenue growth rate, EBITDA margin, and terminal year growth rate, which are affected by expectations about future market or economic conditions, particularly those in emerging markets.
|
|
How We Addressed the Matter in Our Audit
|
We obtained an understanding, evaluated the design and tested the operating effectiveness of controls that address the risks of material misstatement over the Company’s goodwill impairment review process, including controls over management’s review of the significant assumptions described above.
To test the estimated fair value of the Company’s HHS-SA reporting unit, we, along with our valuation specialists, performed audit procedures that included, among others, assessing methodologies and testing the significant assumptions discussed above and the underlying data used by the Company in its analysis. We compared the significant assumptions used by management to current industry and economic trends, changes in the Company’s business model, customer base or product mix, historical operating results and other relevant factors. We assessed the historical accuracy of management’s estimates and performed sensitivity analyses of significant assumptions to evaluate the changes in the fair value of the reporting unit that would result from changes in the assumptions.
|
|
Accounting for RPC Group Plc Business Combination
|
||
Description of the Matter
|
As discussed in Note 2 to the consolidated financial statements, in July 2019, the Company completed the acquisition of the entire outstanding share capital of RPC Group Plc (“RPC”), for aggregate consideration of $6.1 billion. The acquisition was accounted for under the purchase method of accounting and the assets acquired and liabilities assumed have been recorded based on preliminary estimates of fair value and is subject to change based on the finalization of the fair values of the assets acquired and liabilities assumed.
Auditing the Company’s accounting for the preliminary allocation of the purchase price for its acquisition of RPC was complex due to the overall significance of the RPC acquisition and the estimation uncertainty in determining the fair value of property, plant and equipment and identifiable intangible assets, which principally consisted of customer relationships and tradenames. The estimation uncertainty was primarily due to the sensitivity of the respective fair values to underlying assumptions. Given the timing, size and international footprint of the RPC acquisition, the purchase price allocation, including the fair value estimates of the identifiable intangible assets and property, plant and equipment, were recorded on a preliminary basis. A significant assumption used by the Company to estimate the preliminary fair value of these assets was the determination of which of the Company’s historical acquisitions were of a comparable nature to be utilized as a basis for estimating the fair value of RPC’s identified intangible assets and property, plant and equipment. This determination was based upon an analysis by the Company of RPC’s overall business, operations, production processes, equipment, and customer base as compared to the Company’s historical acquisitions.
|
|
How We Addressed the Matter in Our Audit
|
We obtained an understanding, evaluated the design and tested the operating effectiveness of controls that address the risks of material misstatement relating to the estimation of the preliminary fair value of the identifiable intangible assets and property, plant, and equipment. For example, we tested controls over management’s review of the significant assumptions, such as their evaluation of the RPC business versus historical acquisitions executed by the Company to determine similarities and differences which provided the basis for determining which of the historical transactions to use in estimating fair values of the identifiable intangible assets and property, plant and equipment of RPC.
To test the estimate of the preliminary fair value of the acquired identifiable intangible assets and property, plant, and equipment, our audit procedures included, among others, assessing the appropriateness of the other historical acquisitions utilized as a basis in estimating the RPC preliminary fair values and testing the underlying data used by the Company. For example, we obtained an understanding of the nature of the RPC business through audit procedures such as site visits, plant tours, review of financial information and meetings with RPC personnel. Based on this understanding, we compared the nature of the RPC business and operations to the historical acquisitions of the Company used in the preliminary fair value estimates. We then evaluated the reasonableness of the actual historical acquisition fair value results for the identifiable intangible assets and property, plant and equipment and compared those to the values assigned to the equivalent RPC assets. We also tested the mathematical accuracy of historical acquisition averages for identifiable intangible assets and property, plant and equipment.
|
|
Accounting for Income Taxes related to RPC Group Plc
|
||
Description of the Matter
|
As described in Note 2 to the consolidated financial statements, the Company’s acquisition of RPC Group Plc (RPC) expanded their international presence. As discussed in Note 2 to the consolidated financial statements, the RPC acquisition was accounted for under the purchase method of accounting and the assets acquired and liabilities assumed have been recorded based on preliminary estimates of fair value which included any RPC income tax related balances.
Auditing the preliminary income tax account balances recorded in the opening balance sheet and auditing the income tax provision related to RPC was complex given the judgments related to the identification of the various tax jurisdictions and the tax impacts in those jurisdictions, the completeness of the population of the deferred tax balances and uncertain tax positions, and the evaluation of the recoverability of deferred tax assets.
|
|
How We Addressed the Matter in Our Audit
|
To test the RPC income tax accounts, we, along with our income tax professionals, performed procedures that included assessing the completeness and accuracy of the numerous income tax provisions related to RPC. Our procedures included, among others, testing the accuracy of the underlying amounts and inputs used to compute the income tax provisions, testing the key assumptions underlying the estimates of uncertain income tax positions, and testing the inputs used to calculate deferred income tax balances and any related valuation allowances. For example, we compared pre-tax income for the post acquisition period utilized in each jurisdictional tax provision to RPC’s operating results, compared income tax rates to the enacted tax rates specific to each respective jurisdiction and assessed the impact of any permanent adjustments to test each respective jurisdictional income tax provision. We tested the completeness and accuracy of the deferred tax balances based on the historical information available for book versus income tax basis differences and tested the valuation allowances recorded by testing the assumptions underlying the realizability of the deferred income tax assets.
|
Fiscal years ended
|
||||||||||||
September 28,
2019
|
September 29,
2018
|
September 30,
2017
|
||||||||||
Net sales
|
$
|
|
$
|
|
$
|
|
||||||
Costs and expenses:
|
||||||||||||
Cost of goods sold
|
|
|
|
|||||||||
Selling, general and administrative
|
|
|
|
|||||||||
Amortization of intangibles
|
|
|
|
|||||||||
Restructuring and transaction activities
|
(
|
)
|
|
|
||||||||
Operating income
|
|
|
|
|||||||||
Other expense, net
|
|
|
|
|||||||||
Interest expense, net
|
|
|
|
|||||||||
Income before income taxes
|
|
|
|
|||||||||
Income tax expense (benefits)
|
|
(
|
)
|
|
||||||||
Net income
|
$
|
|
$
|
|
$
|
|
||||||
Net income per share:
|
||||||||||||
Basic (see Note 13)
|
$
|
|
$
|
|
$
|
|
||||||
Diluted (see Note 13)
|
$
|
|
$
|
|
$
|
|
Fiscal years ended
|
||||||||||||
September 28,
2019
|
September 29,
2018
|
September 30,
2017
|
||||||||||
Net income
|
$
|
|
$
|
|
$
|
|
||||||
Currency translation
|
(
|
)
|
(
|
)
|
|
|||||||
Pension and postretirement benefits
|
(
|
)
|
|
|
||||||||
Derivative instruments
|
(
|
)
|
|
|
||||||||
Provision for income taxes
|
|
(
|
)
|
(
|
)
|
|||||||
Other comprehensive (loss) income, net of tax
|
(
|
)
|
(
|
)
|
|
|||||||
Comprehensive income
|
$
|
|
$
|
|
$
|
|
September 28,
2019
|
September 29,
2018
|
|||||||
Assets
|
||||||||
Current assets:
|
||||||||
Cash and cash equivalents
|
$
|
|
$
|
|
||||
Accounts receivable
|
|
|
||||||
Inventories
|
|
|
||||||
Prepaid expenses and other current assets
|
|
|
||||||
Total current assets
|
|
|
||||||
Property, plant and equipment
|
|
|
||||||
Goodwill and intangible assets
|
|
|
||||||
Other assets
|
|
|
||||||
Total assets
|
$
|
|
$
|
|
||||
Liabilities and Stockholders' Equity
|
||||||||
Current liabilities:
|
||||||||
Accounts payable
|
$
|
|
$
|
|
||||
Accrued employee costs
|
|
|
||||||
Other current liabilities
|
|
|
||||||
Current portion of long-term debt
|
|
|
||||||
Total current liabilities
|
|
|
||||||
Long-term debt
|
|
|
||||||
Deferred income taxes
|
|
|
||||||
Employee benefit obligations
|
|
|
||||||
Other long-term liabilities
|
|
|
||||||
Total liabilities
|
|
|
||||||
Stockholders' equity:
|
||||||||
Common stock (
|
|
|
||||||
Additional paid-in capital
|
|
|
||||||
Retained earnings
|
|
|
||||||
Accumulated other comprehensive loss
|
(
|
)
|
(
|
)
|
||||
Total stockholders' equity
|
|
|
||||||
Total liabilities and stockholders' equity
|
$
|
|
$
|
|
Common Stock
|
Additional
Paid-in Capital
|
Accumulated Other
Comprehensive Loss
|
Retained
Earnings (Deficit)
|
Total
|
||||||||||||||||
Balance at October 1, 2016
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
||||||||
Share-based compensation expense
|
|
|
|
|
|
|||||||||||||||
Proceeds from issuance of common stock
|
|
|
|
|
|
|||||||||||||||
Derivatives, net of tax
|
|
|
|
|
|
|||||||||||||||
Net income attributable to the Company
|
|
|
|
|
|
|||||||||||||||
Currency translation
|
|
|
|
|
|
|||||||||||||||
Defined benefit pension and retiree health benefit plans, net of tax
|
|
|
|
|
|
|||||||||||||||
Equity issuance, net
|
|
|
|
|
|
|||||||||||||||
Balance at September 30, 2017
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
|
|||||||||
Share-based compensation expense
|
|
|
|
|
|
|||||||||||||||
Proceeds from issuance of common stock
|
|
|
|
|
|
|||||||||||||||
Common stock repurchased and retired
|
|
(
|
)
|
|
(
|
)
|
(
|
)
|
||||||||||||
Derivatives, net of tax
|
|
|
|
|
|
|||||||||||||||
Net income attributable to the Company
|
|
|
|
|
|
|||||||||||||||
Currency translation
|
|
|
(
|
)
|
|
(
|
)
|
|||||||||||||
Defined benefit pension and retiree health benefit plans, net of tax
|
|
|
|
|
|
|||||||||||||||
Balance at September 29, 2018
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
|
|||||||||
Share-based compensation expense
|
|
|
|
|
|
|||||||||||||||
Proceeds from issuance of common stock
|
|
|
|
|
|
|||||||||||||||
Common stock repurchased and retired
|
|
(
|
)
|
|
(
|
)
|
(
|
)
|
||||||||||||
Derivatives, net of tax
|
|
|
(
|
)
|
|
(
|
)
|
|||||||||||||
Net income attributable to the Company
|
|
|
|
|
|
|||||||||||||||
Currency translation
|
|
|
(
|
)
|
|
(
|
)
|
|||||||||||||
Defined benefit pension and retiree health benefit plans, net of tax
|
|
|
(
|
)
|
|
(
|
)
|
|||||||||||||
Balance at September 28, 2019
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
|
Fiscal years ended
|
||||||||||||
September 28,
2019
|
September 29,
2018
|
September 30,
2017
|
||||||||||
Cash Flows from Operating Activities:
|
||||||||||||
Net income
|
$
|
|
$
|
|
$
|
|
||||||
Adjustments to reconcile net cash from operating activities:
|
||||||||||||
Depreciation
|
|
|
|
|||||||||
Amortization of intangibles
|
|
|
|
|||||||||
Non-cash interest expense
|
|
|
|
|||||||||
Share-based compensation expense
|
|
|
|
|||||||||
Deferred income tax
|
(
|
)
|
(
|
)
|
|
|||||||
Settlement of derivatives
|
|
|
|
|||||||||
Transaction activities
|
(
|
)
|
|
|
||||||||
Other non-cash operating activities, net
|
(
|
)
|
|
|
||||||||
Changes in operating assets and liabilities:
|
||||||||||||
Accounts receivable
|
|
(
|
)
|
(
|
)
|
|||||||
Inventories
|
|
(
|
)
|
|
||||||||
Prepaid expenses and other assets
|
|
|
|
|||||||||
Accounts payable and other liabilities
|
(
|
)
|
|
|
||||||||
Net cash from operating activities
|
|
|
|
|||||||||
Cash Flows from Investing Activities:
|
||||||||||||
Additions to property, plant and equipment
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
Proceeds from sale of assets
|
|
|
|
|||||||||
Divestiture of business
|
|
|
|
|||||||||
Acquisition of business
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
Acquisition purchase price derivatives and other
|
(
|
)
|
|
|
||||||||
Net cash from investing activities
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
Cash Flows from Financing Activities:
|
||||||||||||
Proceeds from long-term borrowings
|
|
|
|
|||||||||
Repayment of long-term borrowings
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
Proceeds from issuance of common stock
|
|
|
|
|||||||||
Repurchase of common stock
|
(
|
)
|
(
|
)
|
|
|||||||
Payment of tax receivable agreement
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
Debt financing costs
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
Net cash from financing activities
|
|
|
(
|
)
|
||||||||
Effect of currency translation on cash
|
(
|
)
|
(
|
)
|
|
|||||||
Net change in cash and cash equivalents
|
|
|
(
|
)
|
||||||||
Cash and cash equivalents at beginning of period
|
|
|
|
|||||||||
Cash and cash equivalents at end of period
|
$
|
|
$
|
|
$
|
|
|
2019
|
2018
|
2017
|
|||||||||
Allowance for doubtful accounts, beginning
|
$
|
|
$
|
|
$
|
|
||||||
Acquisition allowance for doubtful accounts
|
|
|
|
|||||||||
Bad debt expense
|
|
|
|
|||||||||
Write-offs against allowance
|
|
(
|
)
|
(
|
)
|
|||||||
Allowance for doubtful accounts, ending
|
$
|
|
$
|
|
$
|
|
Inventories:
|
2019
|
2018
|
||||||
Finished goods
|
$
|
|
$
|
|
||||
Raw materials
|
|
|
||||||
$
|
|
$
|
|
Property, plant and equipment:
|
2019
|
2018
|
||||||
Land, buildings and improvements
|
$
|
|
$
|
|
||||
Equipment and construction in progress
|
|
|
||||||
|
|
|||||||
Less accumulated depreciation
|
(
|
)
|
(
|
)
|
||||
$
|
|
$
|
|
|
Consumer Packaging
International
|
Consumer Packaging
North America
|
Engineered
Materials
|
Health, Hygiene
& Specialties
|
Total
|
|||||||||||||||
Balance as of fiscal 2017
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||
Foreign currency translation adjustment
|
(
|
)
|
(
|
)
|
|
(
|
)
|
(
|
)
|
|||||||||||
Acquisitions
|
|
|
|
|
|
|||||||||||||||
Balance as of fiscal 2018
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||
Foreign currency translation adjustment
|
(
|
)
|
(
|
)
|
|
|
(
|
)
|
||||||||||||
Acquisitions
|
|
|
|
|
|
|||||||||||||||
Dispositions
|
|
|
|
(
|
)
|
(
|
)
|
|||||||||||||
Balance as of fiscal 2019
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
|
Customer
Relationships
|
Trademarks
|
Other
Intangibles
|
Accumulated
Amortization
|
Total
|
|||||||||||||||
Balance as of fiscal 2017
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||||||
Foreign currency translation adjustment
|
(
|
)
|
(
|
)
|
(
|
)
|
|
(
|
)
|
|||||||||||
Amortization expense
|
—
|
—
|
—
|
(
|
)
|
(
|
)
|
|||||||||||||
Acquisition intangibles
|
|
|
|
|
|
|||||||||||||||
Netting of fully amortized intangibles
|
(
|
)
|
(
|
)
|
(
|
)
|
|
|
||||||||||||
Balance as of fiscal 2018
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||||||
Foreign currency translation adjustment
|
(
|
)
|
(
|
)
|
(
|
)
|
|
(
|
)
|
|||||||||||
Amortization expense
|
—
|
—
|
—
|
(
|
)
|
(
|
)
|
|||||||||||||
Acquisition/disposition intangibles
|
|
|
(
|
)
|
|
|
||||||||||||||
Netting of fully amortized intangibles
|
(
|
)
|
|
|
|
|
||||||||||||||
Balance as of fiscal 2019
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
|
Currency
Translation
|
Defined Benefit
Pension and Retiree
Health Benefit Plans
|
Derivative
Instruments
|
Accumulated Other
Comprehensive Loss
|
||||||||||||
Balance as of fiscal 2016
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
||||
Other comprehensive loss
|
|
|
|
|
||||||||||||
Net amount reclassified from accumulated other comprehensive income (loss)
|
|
|
|
|
||||||||||||
Provision for income taxes
|
|
(
|
)
|
(
|
)
|
(
|
)
|
|||||||||
Balance as of fiscal 2017
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
||||
Other comprehensive income
|
(
|
)
|
|
|
(
|
)
|
||||||||||
Net amount reclassified from accumulated other comprehensive income (loss)
|
|
(
|
)
|
|
(
|
)
|
||||||||||
Provision for income taxes
|
|
|
(
|
)
|
(
|
)
|
||||||||||
Balance as of fiscal 2018
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
$
|
(
|
)
|
|||||
Other comprehensive income
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||
Net amount reclassified from accumulated other comprehensive income (loss)
(a)
|
|
(
|
)
|
|
(
|
)
|
||||||||||
Provision for income taxes
|
(
|
)
|
|
|
|
|||||||||||
Balance as of fiscal 2019
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
Facility
|
Maturity Date
|
September 28, 2019
|
September 29, 2018
|
||||||
Term loan
|
October 2022
|
$
|
|
$
|
|
||||
Term loan
|
January 2024
|
|
|
||||||
Term loan
|
July 2026
|
|
|
||||||
Term loan - euro denominated
|
July 2026
|
|
|
||||||
Revolving line of credit
|
May 2024
|
|
|
||||||
|
May 2022
|
|
|
||||||
|
October 2022
|
|
|
||||||
|
July 2023
|
|
|
||||||
|
February 2026
|
|
|
||||||
|
July 2026
|
|
|
||||||
|
July 2027
|
|
|
||||||
Debt discounts and deferred fees
|
(
|
)
|
(
|
)
|
|||||
Capital leases and other
|
Various
|
|
|
||||||
Retired debt
|
Various
|
|
|
||||||
Total long-term debt
|
|
|
|||||||
Current portion of long-term debt
|
(
|
)
|
(
|
)
|
|||||
Long-term debt, less current portion
|
$
|
|
$
|
|
Fiscal Year
|
Maturities
|
||
2020
|
$
|
|
|
2021
|
|
||
2022
|
|
||
2023
|
|
||
2024
|
|
||
Thereafter
|
|
||
$
|
|
Derivatives Instruments
|
Hedge Designation
|
Balance Sheet Location
|
2019
|
2018
|
||||||
Cross-currency swaps
|
Designated
|
Other assets
|
$
|
|
$
|
|
||||
Cross-currency swaps
|
Designated
|
Other long-term liabilities
|
|
|
||||||
Interest rate swaps
|
Designated
|
Other assets
|
|
|
||||||
Interest rate swaps
|
Designated
|
Other long-term liabilities
|
|
|
||||||
Interest rate swaps
|
Not designated
|
Other long-term liabilities
|
|
|
|
Fiscal years ended
|
||||||||||||
Derivatives instruments
|
Statements of Income Location
|
September 28,
2019
|
September 29,
2018
|
September 30,
2017
|
|||||||||
Cross-currency swaps
(a)
|
Interest expense, net
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
||||
Cross-currency swaps
(b)
|
Other expense, net
|
|
|
(
|
)
|
||||||||
Foreign exchange forward contracts
|
Other expense, net
|
|
|
|
|||||||||
Interest rate swaps
|
Interest expense, net
|
|
(
|
)
|
|
(a) |
|
(b) |
|
|
As of the end of fiscal 2019
|
|||||||||||||||||||
Level 1
|
Level 2
|
Level 3
|
Total
|
Impairment
|
||||||||||||||||
Indefinite lived trademarks
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||
Goodwill
|
|
|
|
|
|
|||||||||||||||
Definite lived intangible assets
|
|
|
|
|
|
|||||||||||||||
Property, plant and equipment
|
|
|
|
|
|
|||||||||||||||
Total
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
|
As of the end of fiscal 2018
|
|||||||||||||||||||
Level 1
|
Level 2
|
Level 3
|
Total
|
Impairment
|
||||||||||||||||
Indefinite lived trademarks
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||
Goodwill
|
|
|
|
|
|
|||||||||||||||
Definite lived intangible assets
|
|
|
|
|
|
|||||||||||||||
Property, plant and equipment
|
|
|
|
|
|
|||||||||||||||
Total
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
|
As of the end of fiscal 2017
|
|||||||||||||||||||
Level 1
|
Level 2
|
Level 3
|
Total
|
Impairment
|
||||||||||||||||
Indefinite lived trademarks
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||
Goodwill
|
|
|
|
|
|
|||||||||||||||
Definite lived intangible assets
|
|
|
|
|
|
|||||||||||||||
Property, plant and equipment
|
|
|
|
|
|
|||||||||||||||
Total
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
|
2019
|
2018
|
Amortization Period
|
||||||
Goodwill
|
$
|
|
$
|
|
Indefinite lived
|
||||
Customer relationships
|
|
|
|
||||||
Trademarks (indefinite lived)
|
|
|
Indefinite lived
|
||||||
Trademarks (definite lived)
|
|
|
Not more than
|
||||||
Other intangibles
|
|
|
|
||||||
Accumulated amortization
|
(
|
)
|
(
|
)
|
|||||
Intangible assets, net
|
|
|
|||||||
Total goodwill and intangible assets, net
|
$
|
|
$
|
|
|
Capital
Leases
|
Operating
Leases
|
||||||
2020
|
$
|
|
$
|
|
||||
2021
|
|
|
||||||
2022
|
|
|
||||||
2023
|
|
|
||||||
2024
|
|
|
||||||
Thereafter
|
|
|
||||||
|
$
|
|
||||||
Less: amount representing interest
|
(
|
)
|
||||||
Present value of net minimum lease payments
|
$
|
|
|
2019
|
2018
|
2017
|
|||||||||
Current
|
||||||||||||
U.S.
|
||||||||||||
Federal
|
$
|
|
$
|
|
$
|
|
||||||
State
|
|
|
|
|||||||||
Non-U.S.
|
|
|
|
|||||||||
Total current
|
|
|
|
|||||||||
Deferred:
|
||||||||||||
U.S.
|
||||||||||||
Federal
|
(
|
)
|
(
|
)
|
|
|||||||
State
|
(
|
)
|
|
(
|
)
|
|||||||
Non-U.S.
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
Total deferred
|
(
|
)
|
(
|
)
|
|
|||||||
Expense for income taxes
|
$
|
|
$
|
(
|
)
|
$
|
|
|
2019
|
2018
|
2017
|
|||||||||
U.S. Federal income tax expense at the statutory rate
|
$
|
|
$
|
|
$
|
|
||||||
Adjustments to reconcile to the income tax provision:
|
||||||||||||
U.S. state income tax expense
|
|
|
|
|||||||||
Changes in state valuation allowance
|
|
|
(
|
)
|
||||||||
Research and development credits
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
Share-based compensation
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
U.S. tax reform
|
|
(
|
)
|
|
||||||||
Permanent differences
|
|
|
|
|||||||||
Changes in foreign valuation allowance
|
|
(
|
)
|
|
||||||||
Foreign income taxed in the U.S.
|
|
|
|
|||||||||
Manufacturing tax benefits
|
|
(
|
)
|
(
|
)
|
|||||||
Permanent foreign currency differences
|
|
|
(
|
)
|
||||||||
Rate differences between U.S. and foreign
|
|
|
(
|
)
|
||||||||
Sale of subsidiary
|
(
|
)
|
|
|
||||||||
Other
|
|
|
|
|||||||||
Expense for income taxes
|
$
|
|
$
|
(
|
)
|
$
|
|
|
2019
|
2018
|
||||||
Deferred tax assets:
|
||||||||
Allowance for doubtful accounts
|
$
|
|
$
|
|
||||
Deferred gain on sale-leaseback
|
|
|
||||||
Accrued liabilities and reserves
|
|
|
||||||
Inventories
|
|
|
||||||
Net operating loss carryforward
|
|
|
||||||
Interest expense carryforward
|
|
|
||||||
Alternative minimum tax (AMT) credit carryforward
|
|
|
||||||
Research and development credit carryforward
|
|
|
||||||
Federal and state tax credits
|
|
|
||||||
Other
|
|
|
||||||
Total deferred tax assets
|
|
|
||||||
Valuation allowance
|
(
|
)
|
(
|
)
|
||||
Total deferred tax assets, net of valuation allowance
|
|
|
||||||
Deferred tax liabilities:
|
||||||||
Property, plant and equipment
|
|
|
||||||
Intangible assets
|
|
|
||||||
Other
|
|
|
||||||
Total deferred tax liabilities
|
|
|
||||||
Net deferred tax liability
|
$
|
(
|
)
|
$
|
(
|
)
|
|
2019
|
2018
|
||||||
Beginning unrecognized tax benefits
|
$
|
|
$
|
|
||||
Gross increases – tax positions in prior periods
|
|
|
||||||
Gross increases – current period tax positions
|
|
|
||||||
Gross increases – from RPC acquisition
|
|
|
||||||
Settlements
|
(
|
)
|
|
|||||
Lapse of statute of limitations
|
(
|
)
|
(
|
)
|
||||
Ending unrecognized tax benefits
|
$
|
|
$
|
|
|
Fiscal 2019
|
Fiscal 2018
|
||||||||||||||||||||||||||||||
Change in Projected Benefit Obligations (PBO)
|
North America
|
UK
|
Mainland Europe
|
Total
|
North America
|
UK
|
Mainland Europe
|
Total
|
||||||||||||||||||||||||
Beginning of period
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||||||
Acquisition
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
Service cost
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
Interest cost
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
Assumption change
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
Currency
|
|
(
|
)
|
(
|
)
|
(
|
)
|
|
|
|
|
|||||||||||||||||||||
Actuarial loss (gain)
|
|
|
|
|
(
|
)
|
|
|
(
|
)
|
||||||||||||||||||||||
Benefits paid
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
|
|
(
|
)
|
||||||||||||||||||
End of period
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
|
Fiscal 2019
|
Fiscal 2018
|
||||||||||||||||||||||||||||||
Change in Fair Value of Plan Assets
|
North America
|
UK
|
Mainland Europe
|
Total
|
North America
|
UK
|
Mainland Europe
|
Total
|
||||||||||||||||||||||||
Beginning of period
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||||||
Acquisition
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
Currency
|
|
(
|
)
|
(
|
)
|
(
|
)
|
|
|
|
|
|||||||||||||||||||||
Return on assets
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
Contributions
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
Benefits paid
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
|
|
(
|
)
|
||||||||||||||||||
End of period
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||||||
Underfunded status
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
$
|
|
$
|
(
|
)
|
|
Fiscal 2019
|
|||||||||||
(Percentages)
|
North America
|
UK
|
Mainland Europe
|
|||||||||
Weighted-average assumptions:
|
||||||||||||
Discount rate for benefit obligation
|
|
|
|
|||||||||
Discount rate for net benefit cost
|
|
|
|
|||||||||
Expected return on plan assets for net benefit costs
|
|
|
|
|
Fiscal 2018
|
|||||||||||
(Percentages)
|
North America
|
UK
|
Mainland Europe
|
|||||||||
Weighted-average assumptions:
|
||||||||||||
Discount rate for benefit obligation
|
|
|
|
|||||||||
Discount rate for net benefit cost
|
|
|
|
|||||||||
Expected return on plan assets for net benefit costs
|
|
|
|
Fiscal 2019 Asset Category
|
Level 1
|
Level 2
|
Level 3
|
Total
|
||||||||||||
Cash and cash equivalents
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
U.S. large cap comingled equity funds
|
|
|
|
|
||||||||||||
U.S. mid cap equity mutual funds
|
|
|
|
|
||||||||||||
U.S. small cap equity mutual funds
|
|
|
|
|
||||||||||||
International equity mutual funds
|
|
|
|
|
||||||||||||
Real estate equity investment funds
|
|
|
|
|
||||||||||||
Corporate bond mutual funds
|
|
|
|
|
||||||||||||
Corporate bonds
|
|
|
|
|
||||||||||||
Guaranteed investment account
|
|
|
|
|
||||||||||||
International fixed income funds
|
|
|
|
|
||||||||||||
International insurance policies
|
|
|
|
|
||||||||||||
Total
|
$
|
|
$
|
|
$
|
|
$
|
|
Fiscal 2018 Asset Category
|
Level 1
|
Level 2
|
Level 3
|
Total
|
||||||||||||
Cash and cash equivalents
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
U.S. large cap comingled equity funds
|
|
|
|
|
||||||||||||
U.S. mid cap equity mutual funds
|
|
|
|
|
||||||||||||
U.S. small cap equity mutual funds
|
|
|
|
|
||||||||||||
International equity mutual funds
|
|
|
|
|
||||||||||||
Real estate equity investment funds
|
|
|
|
|
||||||||||||
Corporate bond mutual funds
|
|
|
|
|
||||||||||||
Corporate bonds
|
|
|
|
|
||||||||||||
Guaranteed investment account
|
|
|
|
|
||||||||||||
International fixed income funds
|
|
|
|
|
||||||||||||
Total
|
$
|
|
$
|
|
$
|
|
$
|
|
|
Fiscal 2019
|
|||||||||||||||
North America
|
UK
|
Mainland Europe
|
Total
|
|||||||||||||
2020
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
2021
|
|
|
|
|
||||||||||||
2022
|
|
|
|
|
||||||||||||
2023
|
|
|
|
|
||||||||||||
2024
|
|
|
|
|
||||||||||||
2025-2029
|
|
|
|
|
|
2019
|
2018
|
2017
|
|||||||||
Service cost
|
$
|
|
$
|
|
$
|
|
||||||
Interest cost
|
|
|
|
|||||||||
Amortization of net actuarial loss
|
|
|
|
|||||||||
Expected return on plan assets
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
Net periodic benefit expense (income)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
Asset Category
|
2019
|
2018
|
||||||
Equity securities and equity-like instruments
|
|
%
|
|
%
|
||||
Debt securities and debt-like
|
|
|
||||||
International insurance policies
|
|
|
||||||
Other
|
|
|
||||||
Total
|
|
%
|
|
%
|
|
Expected
Total
Costs
|
Cumulative
Charges
through
Fiscal 2019
|
To be
Recognized
in Future
|
|||||||||
Severance and termination benefits
|
$
|
|
$
|
|
$
|
|
||||||
Facility exit costs
|
|
|
|
|||||||||
Asset impairment
|
|
|
|
|||||||||
Total
|
$
|
|
$
|
|
$
|
|
|
2019
|
2018
|
2017
|
|||||||||
Consumer Packaging International
|
$
|
|
$
|
|
$
|
|
||||||
Consumer Packaging North America
|
|
|
|
|||||||||
Engineered Materials
|
|
|
|
|||||||||
Health, Hygiene & Specialties
|
(
|
)
|
|
|
||||||||
Consolidated
|
$
|
(
|
)
|
$
|
|
$
|
|
|
Employee
Severance
and Benefits
|
Facility
Exit
Costs
|
Non-cash
Impairment
Charges
|
Transaction
Activities
(a)
|
Total
|
|||||||||||||||
Balance as of fiscal 2017
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||
Charges
|
|
|
|
|
|
|||||||||||||||
Cash
|
(
|
)
|
(
|
)
|
|
|
(
|
)
|
||||||||||||
Balance as of fiscal 2018
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||
Charges
|
|
|
|
(
|
)
|
(
|
)
|
|||||||||||||
Non-cash asset impairment
|
|
|
(
|
)
|
|
(
|
)
|
|||||||||||||
Cash
|
(
|
)
|
(
|
)
|
|
|
|
|||||||||||||
Balance as of fiscal 2019
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
|
2019
|
2018
|
||||||||||||||
Number of Shares
(in thousands)
|
Weighted Average
Exercise Price
|
Number of Shares
(in thousands)
|
Weighted Average
Exercise Price
|
|||||||||||||
Options outstanding, beginning of period
|
|
$
|
|
|
$
|
|
||||||||||
Options granted
|
|
|
|
|
||||||||||||
Options exercised
|
(
|
)
|
|
(
|
)
|
|
||||||||||
Options forfeited or cancelled
|
(
|
)
|
|
(
|
)
|
|
||||||||||
Options outstanding, end of period
|
|
$
|
|
|
$
|
|
||||||||||
Option price range at end of period
|
$
|
|
$
|
|
||||||||||||
Options exercisable at end of period
|
|
|
||||||||||||||
Options available for grant at period end
|
|
|
||||||||||||||
Weighted average fair value of options granted during period
|
$
|
|
$
|
|
|
2019
|
2018
|
2017
|
|||||||||
Risk-free interest rate
|
|
%
|
|
%
|
|
%
|
||||||
Dividend yield
|
|
%
|
|
%
|
|
%
|
||||||
Volatility factor
|
|
%
|
|
%
|
|
%
|
||||||
Expected option life
|
|
|
|
Range of
Exercise Prices
|
Number
Outstanding
(in thousands)
|
Intrinsic Value
of Outstanding
(in millions)
|
Weighted
Remaining
Contractual Life
|
Weighted
Exercise Price
|
Number
Exercisable
(in thousands)
|
Intrinsic Value
of Exercisable
(in millions)
|
Unrecognized
Compensation
(in millions)
|
Weighted
Recognition
Period
|
||||||||||||||||||||
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
$
|
|
|
|
2019
|
2018
|
2017
|
|||||||||
Net sales
|
||||||||||||
Consumer Packaging International
|
$
|
|
$
|
|
$
|
|
||||||
Consumer Packaging North America
|
|
|
|
|||||||||
Engineered Materials
|
|
|
|
|||||||||
Health, Hygiene & Specialties
|
|
|
|
|||||||||
Total
|
$
|
|
$
|
|
$
|
|
||||||
Operating income
|
||||||||||||
Consumer Packaging International
|
$
|
|
$
|
|
$
|
|
||||||
Consumer Packaging North America
|
|
|
|
|||||||||
Engineered Materials
|
|
$
|
|
|
||||||||
Health, Hygiene & Specialties
|
|
|
|
|||||||||
Total
|
$
|
|
$
|
|
$
|
|
||||||
Depreciation and amortization
|
||||||||||||
Consumer Packaging International
|
$
|
|
$
|
|
$
|
|
||||||
Consumer Packaging North America
|
|
|
|
|||||||||
Engineered Materials
|
|
|
|
|||||||||
Health, Hygiene & Specialties
|
|
|
|
|||||||||
Total
|
$
|
|
$
|
|
$
|
|
|
2019
|
2018
|
||||||
Total assets:
|
||||||||
Consumer Packaging International
|
$
|
|
$
|
|
||||
Consumer Packaging North America
|
|
|
||||||
Engineered Materials
|
|
|
||||||
Health, Hygiene & Specialties
|
|
|
||||||
Total assets
|
$
|
|
$
|
|
|
2019
|
2018
|
2017
|
|||||||||
Net sales:
|
||||||||||||
North America
|
$
|
|
$
|
|
$
|
|
||||||
South America
|
|
|
|
|||||||||
Europe, Middle East, India, Africa
|
|
|
|
|||||||||
Asia Pacific
|
|
|
|
|||||||||
Total net sales
|
$
|
|
$
|
|
$
|
|
|
2019
|
2018
|
||||||
Long-lived assets:
|
||||||||
North America
|
$
|
|
$
|
|
||||
South America
|
|
|
||||||
Europe, Middle East, India, Africa
|
|
|
||||||
Asia Pacific
|
|
|
||||||
Total Long-lived assets
|
$
|
|
$
|
|
(in percentages)
|
2019
|
2018
|
2017
|
|||||||||
Net sales:
|
||||||||||||
Packaging
|
|
%
|
|
%
|
|
%
|
||||||
Non-packaging
|
|
|
|
|||||||||
Consumer Packaging International
|
|
%
|
|
%
|
|
%
|
||||||
Rigid Open Top
|
|
%
|
|
%
|
|
%
|
||||||
Rigid Closed Top
|
|
|
|
|||||||||
Consumer Packaging North America
|
|
%
|
|
%
|
|
%
|
||||||
Core Films
|
|
%
|
|
%
|
|
%
|
||||||
Retail & Industrial
|
|
|
|
|||||||||
Engineered Materials
|
|
%
|
|
%
|
|
%
|
||||||
Health
|
|
%
|
|
%
|
|
%
|
||||||
Hygiene
|
|
|
|
|||||||||
Specialties
|
|
|
|
|||||||||
Health, Hygiene & Specialties
|
|
%
|
|
%
|
|
%
|
(in millions, except per share amounts)
|
2019
|
2018
|
2017
|
|||||||||
Numerator
|
||||||||||||
Net income attributable to the Company
|
$
|
|
$
|
|
$
|
|
||||||
Denominator
|
||||||||||||
Weighted average common shares outstanding - basic
|
|
|
|
|||||||||
Dilutive shares
|
|
|
|
|||||||||
Weighted average common and common equivalent shares outstanding - diluted
|
|
|
|
|||||||||
Per common share income
|
||||||||||||
Basic
|
$
|
|
$
|
|
$
|
|
||||||
Diluted
|
$
|
|
$
|
|
$
|
|
|
Fiscal 2019
|
|||||||||||||||||||||||
Parent
|
Issuer
|
Guarantor
Subsidiaries
|
Non-Guarantor
Subsidiaries
|
Eliminations
|
Total
|
|||||||||||||||||||
Net sales
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||
Cost of goods sold
|
|
|
|
|
|
|
||||||||||||||||||
Selling, general and administrative
|
|
|
|
|
|
|
||||||||||||||||||
Amortization of intangibles
|
|
|
|
|
|
|
||||||||||||||||||
Restructuring and impairment charges
|
|
|
|
(
|
)
|
|
(
|
)
|
||||||||||||||||
Operating income
|
|
|
|
|
|
|
||||||||||||||||||
Other (income) expense, net
|
|
|
|
(
|
)
|
|
|
|||||||||||||||||
Interest expense, net
|
|
|
|
|
|
|
||||||||||||||||||
Equity in net income of subsidiaries
|
(
|
)
|
(
|
)
|
|
|
|
|
||||||||||||||||
Income (loss) before income taxes
|
|
|
|
|
(
|
)
|
|
|||||||||||||||||
Income tax expense (benefits)
|
|
|
(
|
)
|
|
(
|
)
|
|
||||||||||||||||
Net income (loss)
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||||||||
Currency translation
|
(
|
)
|
|
|
(
|
)
|
|
(
|
)
|
|||||||||||||||
Pension and postretirement benefit
|
(
|
)
|
(
|
)
|
|
(
|
)
|
|
(
|
)
|
||||||||||||||
Derivative instruments
|
(
|
)
|
(
|
)
|
|
(
|
)
|
|
(
|
)
|
||||||||||||||
Provision for income taxes
|
|
|
|
|
(
|
)
|
|
|||||||||||||||||
Comprehensive income (loss)
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
|
Fiscal 2018
|
|||||||||||||||||||||||
Parent
|
Issuer
|
Guarantor
Subsidiaries
|
Non-Guarantor
Subsidiaries
|
Eliminations
|
Total
|
|||||||||||||||||||
Net sales
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||
Cost of goods sold
|
|
|
|
|
|
|
||||||||||||||||||
Selling, general and administrative
|
|
|
|
|
|
|
||||||||||||||||||
Amortization of intangibles
|
|
|
|
|
|
|
||||||||||||||||||
Restructuring and impairment charges
|
|
|
|
|
|
|
||||||||||||||||||
Operating income
|
|
|
|
|
|
|
||||||||||||||||||
Other (income) expense, net
|
|
|
|
|
|
|
||||||||||||||||||
Interest expense, net
|
|
|
|
|
|
|
||||||||||||||||||
Equity in net income of subsidiaries
|
(
|
)
|
(
|
)
|
|
|
|
|
||||||||||||||||
Income (loss) before income taxes
|
|
|
|
|
(
|
)
|
|
|||||||||||||||||
Income tax expense (benefit)
|
(
|
)
|
(
|
)
|
(
|
)
|
|
|
(
|
)
|
||||||||||||||
Net income (loss)
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||||||||
Currency translation
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
|
(
|
)
|
|||||||||||||
Pension and postretirement benefit
|
|
|
|
|
(
|
)
|
|
|||||||||||||||||
Derivative instruments
|
|
|
|
|
(
|
)
|
|
|||||||||||||||||
Provision for income taxes
|
(
|
)
|
(
|
)
|
|
|
|
(
|
)
|
|||||||||||||||
Comprehensive income (loss)
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
|
Fiscal 2017
|
|||||||||||||||||||||||
Parent
|
Issuer
|
Guarantor
Subsidiaries
|
Non-Guarantor
Subsidiaries
|
Eliminations
|
Total
|
|||||||||||||||||||
Net sales
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||
Cost of goods sold
|
|
|
|
|
|
|
||||||||||||||||||
Selling, general and administrative
|
|
|
|
|
|
|
||||||||||||||||||
Amortization of intangibles
|
|
|
|
|
|
|
||||||||||||||||||
Restructuring and impairment charges
|
|
|
|
|
|
|
||||||||||||||||||
Operating income
|
|
|
|
|
|
|
||||||||||||||||||
Other (income) expense, net
|
|
|
(
|
)
|
|
|
|
|||||||||||||||||
Interest expense, net
|
|
|
|
|
|
|
||||||||||||||||||
Equity in net income of subsidiaries
|
(
|
)
|
(
|
)
|
|
|
|
|
||||||||||||||||
Income (loss) before income taxes
|
|
|
|
|
(
|
)
|
|
|||||||||||||||||
Income tax expense (benefit)
|
|
|
|
|
(
|
)
|
|
|||||||||||||||||
Net income (loss)
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||||||||
Currency translation
|
|
|
|
|
(
|
)
|
|
|||||||||||||||||
Pension and postretirement benefit
|
|
|
|
|
(
|
)
|
|
|||||||||||||||||
Derivative instruments
|
|
|
|
|
(
|
)
|
|
|||||||||||||||||
Provision for income taxes
|
(
|
)
|
(
|
)
|
|
|
|
(
|
)
|
|||||||||||||||
Comprehensive income (loss)
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
|
As of fiscal year end 2019
|
|||||||||||||||||||||||
Parent
|
Issuer
|
Guarantor
Subsidiaries
|
Non-Guarantor
Subsidiaries
|
Eliminations
|
Total
|
|||||||||||||||||||
Assets
|
||||||||||||||||||||||||
Current assets:
|
||||||||||||||||||||||||
Cash and cash equivalents
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||
Accounts receivable
|
|
|
|
|
|
|
||||||||||||||||||
Intercompany receivable
|
|
|
|
|
(
|
)
|
|
|||||||||||||||||
Inventories
|
|
|
|
|
|
|
||||||||||||||||||
Prepaid expenses and other current assets
|
|
|
|
|
|
|
||||||||||||||||||
Total current assets
|
|
|
|
|
(
|
)
|
|
|||||||||||||||||
Property, plant and equipment
|
|
|
|
|
|
|
||||||||||||||||||
Goodwill and intangible assets
|
|
|
|
|
|
|
||||||||||||||||||
Investment in subsidiaries
|
|
|
|
|
(
|
)
|
|
|||||||||||||||||
Other assets
|
|
|
|
|
|
|
||||||||||||||||||
Total assets
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||||||||
Liabilities and equity
|
||||||||||||||||||||||||
Current liabilities:
|
||||||||||||||||||||||||
Accounts payable
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||
Accrued expenses and other current liabilities
|
|
|
|
|
|
|
||||||||||||||||||
Intercompany payable
|
|
|
|
|
(
|
)
|
|
|||||||||||||||||
Current portion of long-term debt
|
|
|
|
|
|
|
||||||||||||||||||
Total current liabilities
|
|
|
|
|
(
|
)
|
|
|||||||||||||||||
Long-term debt, less current portion
|
|
|
|
|
|
|
||||||||||||||||||
Deferred income taxes
|
|
|
|
|
|
|
||||||||||||||||||
Other long-term liabilities
|
|
|
|
|
|
|
||||||||||||||||||
Total long-term liabilities
|
|
|
|
|
|
|
||||||||||||||||||
Total liabilities
|
|
|
|
|
(
|
)
|
|
|||||||||||||||||
Total equity (deficit)
|
|
|
|
|
(
|
)
|
|
|||||||||||||||||
Total liabilities and equity (deficit)
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
|
As of fiscal year end 2018
|
|||||||||||||||||||||||
Parent
|
Issuer
|
Guarantor
Subsidiaries
|
Non-Guarantor
Subsidiaries
|
Eliminations
|
Total
|
|||||||||||||||||||
Assets
|
||||||||||||||||||||||||
Current assets:
|
||||||||||||||||||||||||
Cash and cash equivalents
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||
Accounts receivable, net
|
|
|
|
|
|
|
||||||||||||||||||
Intercompany receivable
|
|
|
|
|
(
|
)
|
|
|||||||||||||||||
Inventories
|
|
|
|
|
|
|
||||||||||||||||||
Prepaid expenses and other current assets
|
|
|
|
|
|
|
||||||||||||||||||
Total current assets
|
|
|
|
|
(
|
)
|
|
|||||||||||||||||
Property, plant and equipment
|
|
|
|
|
|
|
||||||||||||||||||
Goodwill and intangible assets
|
|
|
|
|
|
|
||||||||||||||||||
Investment in subsidiaries
|
|
|
|
|
(
|
)
|
|
|||||||||||||||||
Other assets
|
|
|
|
|
|
|
||||||||||||||||||
Total assets
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||||||||
Liabilities and equity
|
||||||||||||||||||||||||
Current liabilities:
|
||||||||||||||||||||||||
Accounts payable
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||
Accrued expenses and other current liabilities
|
|
|
|
|
|
|
||||||||||||||||||
Intercompany payable
|
|
|
|
|
(
|
)
|
|
|||||||||||||||||
Current portion of long-term debt
|
|
|
|
|
|
|
||||||||||||||||||
Total current liabilities
|
|
|
|
|
(
|
)
|
|
|||||||||||||||||
Long-term debt, less current portion
|
|
|
|
|
|
|
||||||||||||||||||
Deferred income taxes
|
|
|
|
|
|
|
||||||||||||||||||
Other long-term liabilities
|
|
|
|
|
|
|
||||||||||||||||||
Total long-term liabilities
|
|
|
|
|
|
|
||||||||||||||||||
Total liabilities
|
|
|
|
|
(
|
)
|
|
|||||||||||||||||
—
|
—
|
—
|
—
|
—
|
—
|
|||||||||||||||||||
Total equity (deficit)
|
|
|
|
|
(
|
)
|
|
|||||||||||||||||
Total liabilities and equity (deficit)
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
|
Fiscal 2019
|
|||||||||||||||||||||||
Parent
|
Issuer
|
Guarantor
Subsidiaries
|
Non-Guarantor
Subsidiaries
|
Eliminations
|
Total
|
|||||||||||||||||||
Cash Flow from Operating Activities
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||
Cash Flow from Investing Activities
|
||||||||||||||||||||||||
Additions to property, plant and equipment
|
|
|
(
|
)
|
(
|
)
|
|
(
|
)
|
|||||||||||||||
Divestiture of business
|
|
|
|
|
|
|
||||||||||||||||||
Acquisition purchase price derivatives
|
|
(
|
)
|
|
|
|
(
|
)
|
||||||||||||||||
(Contributions) distributions to/from subsidiaries
|
|
(
|
)
|
|
|
|
|
|||||||||||||||||
Intercompany advances (repayments)
|
|
|
|
|
(
|
)
|
|
|||||||||||||||||
Acquisition of business
|
|
|
(
|
)
|
(
|
)
|
|
(
|
)
|
|||||||||||||||
Net cash from investing activities
|
|
(
|
)
|
(
|
)
|
(
|
)
|
|
(
|
)
|
||||||||||||||
Cash Flow from Financing Activities
|
||||||||||||||||||||||||
Proceeds from long-term borrowings
|
|
|
|
|
|
|
||||||||||||||||||
Repayment of long-term borrowings
|
|
(
|
)
|
(
|
)
|
(
|
)
|
|
(
|
)
|
||||||||||||||
Proceeds from issuance of common stock
|
|
|
|
|
|
|
||||||||||||||||||
Repurchase of common stock
|
(
|
)
|
|
|
|
|
(
|
)
|
||||||||||||||||
Payment of tax receivable agreement
|
(
|
)
|
|
|
|
|
(
|
)
|
||||||||||||||||
Debt financing costs
|
|
(
|
)
|
|
|
|
(
|
)
|
||||||||||||||||
Changes in intercompany balances
|
|
|
(
|
)
|
(
|
)
|
|
|
||||||||||||||||
Contribution from Parent
|
|
|
|
|
(
|
)
|
|
|||||||||||||||||
Net cash from financing activities
|
(
|
)
|
|
(
|
)
|
|
(
|
)
|
|
|||||||||||||||
Effect of currency translation on cash
|
|
|
|
(
|
)
|
|
(
|
)
|
||||||||||||||||
Net change in cash and cash equivalents
|
|
(
|
)
|
(
|
)
|
|
|
|
||||||||||||||||
Cash and cash equivalents at beginning of period
|
|
|
|
|
|
|
||||||||||||||||||
Cash and cash equivalents at end of period
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
|
Fiscal 2018
|
|||||||||||||||||||||||
Parent
|
Issuer
|
Guarantor
Subsidiaries
|
Non-Guarantor
Subsidiaries
|
Eliminations
|
Total
|
|||||||||||||||||||
Cash Flow from Operating Activities
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||
Cash Flow from Investing Activities
|
||||||||||||||||||||||||
Additions to property, plant and equipment
|
|
(
|
)
|
(
|
)
|
(
|
)
|
|
(
|
)
|
||||||||||||||
Proceeds from sale of assets
|
|
|
|
|
|
|
||||||||||||||||||
(Contributions) distributions to/from subsidiaries
|
|
(
|
)
|
|
|
|
|
|||||||||||||||||
Intercompany advances (repayments)
|
|
|
|
|
(
|
)
|
|
|||||||||||||||||
Acquisition of business
|
|
|
(
|
)
|
(
|
)
|
|
(
|
)
|
|||||||||||||||
Net cash from investing activities
|
|
(
|
)
|
(
|
)
|
(
|
)
|
|
(
|
)
|
||||||||||||||
Cash Flow from Financing Activities
|
||||||||||||||||||||||||
Proceeds from long-term borrowings
|
|
|
|
|
|
|
||||||||||||||||||
Repayment of long-term borrowings
|
|
(
|
)
|
(
|
)
|
(
|
)
|
|
(
|
)
|
||||||||||||||
Proceeds from issuance of common stock
|
|
|
|
|
|
|
||||||||||||||||||
Repurchase of common stock
|
(
|
)
|
|
|
|
|
(
|
)
|
||||||||||||||||
Payment of tax receivable agreement
|
(
|
)
|
|
|
|
|
(
|
)
|
||||||||||||||||
Debt financing costs
|
|
(
|
)
|
|
|
|
(
|
)
|
||||||||||||||||
Changes in intercompany balances
|
|
|
(
|
)
|
(
|
)
|
|
|
||||||||||||||||
Contribution from Parent
|
|
|
|
|
(
|
)
|
|
|||||||||||||||||
Net cash from financing activities
|
(
|
)
|
|
|
(
|
)
|
(
|
)
|
|
|||||||||||||||
Effect of currency translation on cash
|
|
|
|
(
|
)
|
|
(
|
)
|
||||||||||||||||
Net change in cash and cash equivalents
|
|
|
(
|
)
|
(
|
)
|
|
|
||||||||||||||||
Cash and cash equivalents at beginning of period
|
|
|
|
|
|
|
||||||||||||||||||
Cash and cash equivalents at end of period
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
|
Fiscal 2017
|
|||||||||||||||||||||||
Parent
|
Issuer
|
Guarantor
Subsidiaries
|
Non-Guarantor
Subsidiaries
|
Eliminations
|
Total
|
|||||||||||||||||||
Cash Flow from Operating Activities
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||
Cash Flow from Investing Activities
|
||||||||||||||||||||||||
Additions to property, plant and equipment
|
|
(
|
)
|
(
|
)
|
(
|
)
|
|
(
|
)
|
||||||||||||||
Proceeds from sale of assets
|
|
|
|
|
|
|
||||||||||||||||||
(Contributions) distributions to/from subsidiaries
|
(
|
)
|
(
|
)
|
|
|
|
|
||||||||||||||||
Intercompany advances (repayments)
|
|
|
|
|
(
|
)
|
|
|||||||||||||||||
Acquisition of business
|
|
|
(
|
)
|
|
|
(
|
)
|
||||||||||||||||
Other investing activities, net
|
|
|
|
|
|
|
||||||||||||||||||
Net cash from investing activities
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
|
(
|
)
|
|||||||||||||
Cash Flow from Financing Activities
|
||||||||||||||||||||||||
Proceeds from long-term borrowings
|
|
|
|
|
|
|
||||||||||||||||||
Repayment of long-term borrowings
|
|
(
|
)
|
(
|
)
|
(
|
)
|
|
(
|
)
|
||||||||||||||
Proceeds from issuance of common stock
|
|
|
|
|
|
|
||||||||||||||||||
Payment of tax receivable agreement
|
(
|
)
|
|
|
|
|
(
|
)
|
||||||||||||||||
Debt financing costs
|
|
(
|
)
|
|
|
|
(
|
)
|
||||||||||||||||
Changes in intercompany balances
|
|
|
(
|
)
|
(
|
)
|
|
|
||||||||||||||||
Contribution from Parent
|
|
|
|
|
(
|
)
|
|
|||||||||||||||||
Net cash from financing activities
|
|
(
|
)
|
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||||||||
Effect of currency translation on cash
|
|
|
|
|
|
|
||||||||||||||||||
Net change in cash and cash equivalents
|
|
(
|
)
|
|
|
|
(
|
)
|
||||||||||||||||
Cash and cash equivalents at beginning of period
|
|
|
|
|
|
|
||||||||||||||||||
Cash and cash equivalents at end of period
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
|
2019
|
2018
|
||||||||||||||||||||||||||||||
First
|
Second
|
Third
|
Fourth
|
First
|
Second
|
Third
|
Fourth
|
|||||||||||||||||||||||||
Net sales
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||||||
Cost of goods sold
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
Gross profit
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||
Net income
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||||||
Net income per share:
|
||||||||||||||||||||||||||||||||
Basic
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||||||
Diluted
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
Exhibit No
|
Description of Exhibit
|
||
Agreement and Plan of Merger, dated as of July 30, 2015, by and among AVINTIV Inc., Berry Plastics Group, Inc., Berry Plastics Acquisition Corporation IX and Blackstone Capital Partners (Cayman) V L.P., as the security holder representative (the Exhibits and Disclosure Schedules have been omitted pursuant to Item 601(b)(2) of Regulation S-K and will be provided to the SEC upon request) (incorporated by reference to Exhibit 2.1 to the Company's Form 8-K filed on August 5, 2015).
|
|||
Agreement and Plan of Merger, dated as of August 24, 2016, by and among Berry Plastics Group, Inc., Berry Plastics Corporation, Berry Plastics Acquisition Corporation XVI, Berry Plastics Acquisition Corporation XV, LLC and AEP Industries Inc. (the Exhibits and Disclosure Schedules have been omitted pursuant to Item 601(b)(2) of Regulation SK and will be provided to the SEC upon request) (incorporated by reference to Annex A Amendment No. 1 to the Company's Registration Statement S-4 filed on November 8, 2016).
|
|||
Amendment No. 1 to the Agreement and Plan of Merger, dated as of December 7, 2016, by and among Berry Plastics Group, Inc., Berry Plastics Corporation, Berry Plastics Acquisition Corporation XVI, Berry Plastics Acquisition Corporation XV, LLC and AEP Industries Inc. (incorporated by reference to Annex A of Amendment No. 2 to Berry's Registration Statement on Form S-4 filed on December 9, 2016).
|
|||
Rule 2.7 Announcement, dated as of March 8, 2019 (incorporated by reference to Exhibit 2.1 to the Company’s Current Report on Form 8-K filed on March 14, 2019).
|
|||
Co-Operation Agreement, dated as of March 8, 2019, by and among Berry Global Group, Inc., Berry Global International Holdings Limited and RPC Group Plc (incorporated by reference to Exhibit 2.2 to the Company’s Current Report on Form 8-K filed on March 14, 2019).
|
|||
Amended and Restated Certificate of Incorporation of Berry Global Group, Inc., as amended through March 6, 2019 (incorporated by reference to Exhibit 3.1 to the Company's Quarterly Report on Form 10-Q filed on May 2, 2019).
|
|||
Amended and Restated Bylaws of Berry Global Group, Inc., as amended and restated effective as of March 6, 2019 (incorporated by reference to Exhibit 3.2 to the Company’s Current Report on Form 8-K filed on March 8, 2019).
|
|||
Indenture, dated as of May 12, 2014, by and among Berry Plastics Corporation, the guarantors party thereto and U.S. Bank National Association, as Trustee, relating to the 5.50% second priority senior secured notes due 2022 (incorporated by reference to Exhibit 4.2 of the Company's Current Report on Form 8-K filed on May 13, 2014).
|
|||
Indenture, dated as of June 5, 2015, by and among Berry Plastics Corporation, the guarantors party thereto and U.S. Bank National Association, as Trustee, relating to the 5.125% second priority senior secured notes due 2023 (incorporated by reference to Exhibit 4.2 to the Company's Form 8-K filed on June 5, 2015).
|
|||
Indenture, dated as of October 1, 2015, by and between Berry Plastics Escrow Corporation, as Issuer, and U.S. Bank National Association, as Trustee, relating to the 6.00% second priority senior secured notes due 2022 (incorporated by reference to Exhibit 4.1 to the Company's Form 8-K filed on October 6, 2015).
|
|||
First Supplemental Indenture, dated as of October 1, 2015, by and between Berry Plastics Corporation, Berry Plastics Group, Inc., the subsidiaries of Berry Plastics Corporation party thereto, Berry Plastics Escrow Corporation, and U.S. Bank National Association, as Trustee, relating to the Indenture, by and between Berry Plastics Escrow Corporation, as Issuer, and U.S. Bank, National Association, as Trustee, relating to the 6.00% second priority senior secured notes due 2022, dated October 1, 2015 (incorporated by reference to Exhibit 4.1 to the Company's Form 8-K filed on October 6, 2015).
|
|||
Registration Rights Agreement, dated as of October 1, 2015, by and between Berry Plastics Corporation, Berry Plastics Group, Inc., each subsidiary of Berry Plastics Corporation identified therein, and Goldman, Sachs & Co., and Credit Suisse, on behalf of themselves and as representatives of the initial purchasers, relating to the 6.00% second priority senior secured notes due 2022 (incorporated by reference to Exhibit 4.1 to the Company's Form 8-K filed on October 6, 2015).
|
|||
Form of common stock certificate of Berry Plastics Group, Inc. (incorporated by reference to Exhibit 4.27 of Amendment No. 5 to the Company's Registration Statement on Form S-1 filed on September 19, 2012).
|
|||
Indenture, by and between Berry Global Escrow Corporation and U.S. Bank National Association, as Trustee and Collateral Agent, relating to the 4.875% First Priority Senior Secured Notes due 2026, dated June 5, 2019 (incorporated by reference to Exhibit 4.1 to the Company’s Form 8-K filed on June 6, 2019).
|
Supplemental Indenture, among Berry Global Group, Inc., Berry Global, Inc., Berry Global Escrow Corporation, each of the parties identified as a Subsidiary Guarantor thereon, and U.S. Bank National Association, as Trustee, relating to the 4.875% First Priority Senior Secured Notes due 2026, dated July 1, 2019 (incorporated by reference to Exhibit 4.1 to the Company’s Form 8-K filed on July 2, 2019).
|
|||
Indenture, by and between Berry Global Escrow Corporation and U.S. Bank National Association, as Trustee and Collateral Agent, relating to the 5.625% Second Priority Senior Secured Notes due 2027, dated June 5, 2019 (incorporated by reference to Exhibit 4.2 to the Company’s Form 8-K filed on June 6, 2019).
|
|||
Supplemental Indenture, among Berry Global Group, Inc., Berry Global, Inc., Berry Global Escrow Corporation, each of the parties identified as a Subsidiary Guarantor thereon, and U.S. Bank National Association, as Trustee, relating to the 5.625% Second Priority Senior Secured Notes due 2027, dated July 1, 2019 (incorporated by reference to Exhibit 4.2 to the Company’s Form 8-K filed on July 2, 2019).
|
|||
*
|
Description of Securities
|
||
$850,000,000 Third Amended and Restated Revolving Credit Agreement, dated as of May 1, 2019, by and among Berry Global, Inc., Berry Global Group, Inc., the lenders party thereto, Bank of America, N.A., as collateral agent and administrative agent, and the financial institutions party thereto (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed on May 6, 2019).
|
|||
U.S. $1,200,000,000 Second Amended and Restated Credit Agreement, dated as of April 3, 2007, by and among Berry Plastics Corporation formerly known as Berry Plastics Holding Corporation, Berry Plastics Group, Inc., Credit Suisse, Cayman Islands Branch, as collateral and administrative agent, the lenders party thereto from time to time, and the other financial institutions party thereto (incorporated by reference to Exhibit 10.1(b) to Berry Plastics Corporation's Current Report on Form 8-K filed on April 10, 2007).
|
|||
Second Amended and Restated Intercreditor Agreement, dated as of February 5, 2008, by and among Berry Plastics Group, Inc., Berry Plastics Corporation, certain subsidiaries identified as parties thereto, Bank of America, N.A. and Credit Suisse, Cayman Islands Branch as first lien agents, and U.S. Bank National Association, as successor in interest to Wells Fargo Bank, N.A., as trustee (incorporated by reference to Exhibit 10.3 to the Company's Form 10-K filed on November 23, 2015).
|
|||
U.S. $1,147,500,000 and $814,375,000 Incremental Assumption Agreement, dated as of February 10, 2017 by and among Berry Plastics Group, Inc., Berry Plastics Corporation and certain of its subsidiaries referenced therein, Credit Suisse AG, Cayman Islands Branch, as administrative agent for the lenders under the term loan credit agreement referenced therein, Citibank, N.A., as initial Term I lender and Citibank, N.A., as incremental term J lender therein. (incorporated by reference to Exhibit 10.7 to the Company's Annual Report on Form 10-K filed on November 21, 2017).
|
|||
U.S. $1,644,750,000 and $498,750,000 Incremental Assumption Agreement, dated as of August 10, 2017, by and among Berry Plastics Group, Inc., Berry Plastics Corporation and certain of its subsidiaries referenced therein, Credit Suisse AG, Cayman Islands Branch, as administrative agent for the lenders under the term loan credit agreement referenced therein, Wells Fargo Bank, National Association, as initial Term M lender and Wells Fargo Bank, National Association, as initial Term N lender therein (incorporated by reference to Exhibit 10.8 to the Company's Annual Report on Form 10-K filed on November 21, 2017).
|
|||
U.S. $900,000,000 and $814,375,000 Incremental Assumption Agreement, dated as of November 27, 2017, by and among Berry Global Group, Inc., Berry Global, Inc. and certain of its subsidiaries referenced therein, Credit Suisse AG, Cayman Islands Branch, as administrative agent for the lenders under the term loan credit agreement referenced therein, Citibank, N.A., as initial Term O Lender, and Citibank, N.A., as initial Term P Lender therein. (incorporated by reference to Exhibit 10.1 to the Company's Quarterly Report on Form 10-Q filed on February 7, 2018).
|
|||
U.S. $ 1,644,750,000 and $496,250,000 Incremental Assumption Agreement and Amendment, dated as of February 12, 2018, by and among Berry Global Group, Inc., Berry Global, Inc. and certain of its subsidiaries referenced therein, Credit Suisse AG, Cayman Islands Branch, as administrative agent for the lenders under the term loan credit agreement referenced therein, Citibank, N.A., as initial Term Q lender, and Citibank, N.A., as initial Term R lender therein (incorporated by reference to Exhibit 10.2 to the Company's Quarterly Report on Form 10-Q filed on May 3, 2018).
|
|||
U.S. $800,000,000 and $814,375,000 Incremental Assumption Agreement, dated as of May 16, 2018, by and among Berry Global Group, Inc., Berry Global, Inc. and certain of its subsidiaries referenced therein, Credit Suisse AG, Cayman Islands Branch, as administrative agent for the lenders under the term loan credit agreement referenced therein, Citibank, N.A., as initial Term S lender, and Citibank, N.A., as initial Term T lender therein (incorporated by reference to Exhibit 10.1 to the Company's Quarterly Report on Form 10-Q filed on August 3, 2018).
|
Incremental Assumption Agreement and Amendment, among Berry Global Group, Inc., Berry Global, Inc. and certain subsidiaries of Berry Global, Inc., as Loan Parties, Credit Suisse AG, Cayman Islands Branch, as Administrative Agent, Goldman Sachs Bank USA, as Initial Term U Lender, and Goldman Sachs Bank USA, as Initial Term V Lender, dated as of July 1, 2019 (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on July 2, 2019).
|
|||
Amendment and Waiver to Equipment Lease Agreement, dated as of January 19, 2011, between Chicopee, Inc., as Lessee and Gossamer Holdings, LLC, as Lessor (incorporated by reference to Exhibit 10.16 to AVINTIV Specialty Materials Inc.'s Registration Statement Form S-4 filed on October 25, 2011).
|
|||
Second Amendment to Equipment Lease Agreement, dated as of October 7, 2011, between Chicopee, Inc., as Lessee and Gossamer Holdings, LLC, as Lessor (incorporated by reference to Exhibit 10.17 to AVINTIV Specialty Materials Inc.'s Registration Statement Form S-4 filed on October 25, 2011).
|
|||
Third Amendment to Equipment Lease Agreement, dated as of February 28, 2012, between Chicopee, Inc., as Lessee and Gossamer Holdings, LLC, as Lessor (incorporated by reference to Exhibit 10.1 to AVINTIV Specialty Materials Inc.'s Quarterly Report on Form 10-Q filed on May 15, 2012).
|
|||
Fourth Amendment to Equipment Lease Agreement, dated as of March 22, 2013, between Chicopee, Inc., as Lessee and Gossamer Holdings, LLC, as Lessor (incorporated by reference to Exhibit 10.1 to AVINTIV Specialty Materials Inc.'s Quarterly Report on Form 10-Q filed on May 9, 2013).
|
|||
†
|
2006 Equity Incentive Plan (incorporated by reference to Exhibit 10.8 to Berry Plastics Corporation's Registration Statement Form S-4 filed on November 2, 2006).
|
||
†
|
Amendment No. 2 to the Berry Plastics Group, Inc., 2006 Equity Incentive Plan (incorporated by reference to Exhibit 10.9 to the Company's Form 10-K filed on December 11, 2013).
|
||
†
|
Amendment No. 3 to Berry Plastics Group, Inc. 2006 Equity Incentive Plan (incorporated by reference to Exhibit 10.1 to the Company's Form 8-K filed on March 10, 2015).
|
||
†
|
Form of 2016 Omnibus Amendment to Awards Granted Under the Berry Plastics Group, Inc. 2006 Equity Incentive Plan (incorporated by reference to Exhibit 10.2 to the Company's Form 8-K filed on July 22, 2016).
|
||
†
|
Omnibus amendment to awards granted under the Berry Plastics Group, Inc., 2006 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.10 to the Company's Form 10-K filed on December 11, 2013).
|
||
†
|
Form of Performance-Based Stock Option Agreement of Berry Plastics Group, Inc. (incorporated by reference to Exhibit 10.9 to Berry Plastics Corporation's Registration Statement Form S-4 filed on November 2, 2006).
|
||
†
|
Form of Accreting Stock Option Agreement of Berry Plastics Group, Inc. (incorporated by reference to Exhibit 10.10 to Berry Plastics Corporation's Registration Statement Form S-4 filed on November 2, 2006).
|
||
†
|
Form of Time-Based Stock Option Agreement of Berry Plastics Group, Inc. (incorporated by reference to Exhibit 10.11 to Berry Plastics Corporation's Registration Statement Form S-4 filed on November 2, 2006).
|
||
†
|
Form of Performance-Based Stock Appreciation Rights Agreement of Berry Plastics Group, Inc. (incorporated by reference to Exhibit 10.12 to Berry Plastics Corporation's Registration Statement Form S-4 filed on November 2, 2006).
|
||
†
|
Employment Agreement of Thomas E. Salmon (incorporated by reference to Exhibit 10.1 to the Company's Form 8-K filed on February 6, 2017).
|
||
†
|
Income Tax Receivable Agreement, dated as of November 29, 2012, by and among Berry Plastics Group, Inc. and Apollo Management Fund VI, L.P. (incorporated by reference to Exhibit 10.25 to the Company's Form 10-K filed on December 17, 2012).
|
||
†
|
Berry Plastics Group, Inc. Executive Bonus Plan, amended and restated December 22, 2015, effective as of September 27, 2015 (incorporated by reference to Exhibit 10.1 to the Company's Form 8-K filed on December 28, 2015).
|
||
†
|
Berry Plastics Group, Inc. 2012 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.27 to the Company's Form 10-K filed on December 17, 2012).
|
||
†
|
Amendment No. 1 to the Berry Plastics Group, Inc., 2012 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.31 to the Company's Form 10-K filed on December 11, 2013).
|
||
†
|
Omnibus amendment to awards granted under the Berry Plastics Group, Inc., 2012 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.32 to the Company's Form 10-K filed on December 11, 2013).
|
||
†
|
Amendment No. 2 to the Berry Plastics Group, Inc. 2012 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.2 to the Company's Form 8-K filed on March 10, 2015).
|
||
†
|
Form of 2016 Omnibus Amendment to Awards Granted Under the Berry Plastics Group, Inc. 2012 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.3 to the Company's Form 8-K filed on July 22, 2016).
|
||
†
|
2015 Berry Plastics Group, Inc. Long-Term Incentive Plan (incorporated by reference to Exhibit 10.3 to the Company's Form 8-K filed on March 10, 2015.
|
||
†
|
First Amendment to 2015 Berry Plastics Group, Inc. Long-Term Incentive Plan (incorporated by reference to Exhibit 10.1 to the Company's Form 8-K filed on March 6, 2018).
|
†
|
Form of 2016 Omnibus Amendment to Awards Granted Under the Berry Plastics Group, Inc. 2015 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.4 to the Company's Form 8-K filed on July 22, 2016).
|
||
†
|
Fourth Amended and Restated Stockholders Agreement, by and among Berry Plastics Group, Inc., and the stockholders of the Corporation listed on schedule A thereto, dated as of January 15, 2015 (incorporated by reference to Exhibit 10.1 to the Company's Form 10-Q filed on January 30, 2015).
|
||
†
|
Employment Agreement, dated January 1, 2002, between the Berry Plastics Corporation and Curtis Begle (incorporated by reference to Exhibit 10.1 to the Company's Form 10-Q filed on January 31, 2014).
|
||
†
|
Amendment No. 1 to Employment Agreement, dated as of September 13, 2006, by and between the Berry Plastics Corporation and Curtis Begle (incorporated by reference to Exhibit 10.3 to the Company's Form 10-Q filed on January 31, 2014).
|
||
†
|
Amendment No. 2 to Employment Agreement, dated December 31, 2008, by and between the Berry Plastics Corporation and Curtis Begle (incorporated by reference to Exhibit 10.4 to the Company's Form 10-Q filed on January 31, 2014).
|
||
†
|
Amendment No. 3 to Employment Agreement, dated August 1, 2010, by and between the Berry Plastics Corporation and Curtis L. Begle (incorporated by reference to Exhibit 10.5 to the Company's Form 10-Q filed on January 31, 2014).
|
||
†
|
Amendment No. 4 to Employment Agreement, dated December 16, 2011, by and between the Berry Plastics Corporation and Curtis L. Begle (incorporated by reference to Exhibit 10.6 to the Company's Form 10-Q filed on January 31, 2014).
|
||
†
|
Employment Agreement, dated February 28, 1998, between Berry Plastics Corporation and Mark Miles, together with amendments dated February 28, 2003, September 13, 2006, December 31, 2008, and December 31, 2011 (incorporated by reference to Exhibit 10.40 to the Company's Form 10-K filed on November 30, 2016).
|
||
†
|
Form of Amendment to Employment Agreement by and between Berry Plastics Corporation and each of Curtis L Begle, Mark W. Miles, and Thomas E. Salmon (incorporated by reference to Exhibit 10.1 to the Company's Form 8-K filed on July 22, 2016).
|
||
†
|
Senior Executive Employment Contract dated as of September 30, 2015 by and between PGI Specialty Materials Inc. and Jean Marc Galvez, together with the International Assignment Letter dated December 18, 2016 from Berry Global, Inc. (f/k/a Berry Plastics Corporation) (incorporated by reference to Exhibit 10.2 to the Company's Quarterly Report on Form 10-Q filed on February 7, 2018).
|
||
*
|
Subsidiaries of the Registrant.
|
||
*
|
Consent of Independent Registered Public Accounting Firm
|
||
*
|
Rule 13a-14(a)/15d-14(a) Certification of the Chief Executive Officer
|
||
*
|
Rule 13a-14(a)/15d-14(a) Certification of the Chief Financial Officer
|
||
*
|
Section 1350 Certification of the Chief Executive Officer
|
||
*
|
Section 1350 Certification of the Chief Financial Officer
|
||
101.INS
|
Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)
|
||
101.SCH
|
Inline XBRL Taxonomy Extension Schema Document
|
||
101.CAL
|
Inline XBRL Taxonomy Extension Calculation Linkbase Document
|
||
101.DEF
|
Inline XBRL Taxonomy Extension Definition Linkbase Document
|
||
101.LAB
|
Inline XBRL Taxonomy Extension Label Linkbase Document
|
||
101.PRE
|
Inline XBRL Taxonomy Extension Presentation Linkbase Document
|
||
104
|
Cover Page Interactive Date File (formatted as Inline XBRL and contained in Exhibit 101)
|
* |
Filed herewith.
|
† |
Management contract or compensatory plan or arrangement.
|
BERRY GLOBAL GROUP, INC.
|
|||
By
|
/s/ Thomas E. Salmon
|
||
Thomas E. Salmon
|
|||
Chief Executive Officer
|
Signature
|
Title
|
Date
|
||
/s/ Thomas E. Salmon
|
Chief Executive Officer and Chairman of the Board of Directors and Director (Principal Executive Officer)
|
November 22, 2019
|
||
Thomas E. Salmon
|
||||
/s/ Mark W. Miles
|
Chief Financial Officer (Principal Financial Officer)
|
November 22, 2019
|
||
Mark W. Miles
|
||||
/s/ James M. Till
|
Executive Vice President and Controller (Principal Accounting Officer)
|
November 22, 2019
|
||
James M. Till
|
||||
/s/ B. Evan Bayh
|
Director
|
November 22, 2019
|
||
B. Evan Bayh
|
||||
/s/ Jonathan F. Foster
|
Director
|
November 22, 2019
|
||
Jonathan F. Foster
|
||||
/s/ Idalene F. Kesner
|
Director
|
November 22, 2019
|
||
Idalene F. Kesner
|
||||
/s/ Carl J. Rickertsen
|
Director
|
November 22, 2019
|
||
Carl J. Rickertsen
|
||||
/s/ Ronald S. Rolfe
|
Director
|
November 22, 2019
|
||
Ronald S. Rolfe
|
||||
/s/ Paula Sneed
|
Director
|
November 22, 2019
|
||
Paula Sneed
|
||||
/s/ Robert A. Steele
|
Director
|
November 22, 2019
|
||
Robert A. Steele
|
||||
/s/ Stephen E. Sterrett
|
Director
|
November 22, 2019
|
||
Stephen E. Sterrett
|
||||
/s/ Scott B. Ullem
|
Director
|
November 22, 2019
|
||
Scott B. Ullem
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
---|
DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
---|
No information found
Customers
Customer name | Ticker |
---|---|
Performance Food Group Company | PFGC |
Sysco Corporation | SYY |
Yum! Brands, Inc. | YUM |
No Suppliers Found
Price
Yield
Owner | Position | Direct Shares | Indirect Shares |
---|